We also showed that EVs from the plasma of CRC‐LM patients significantly activated the NOD1 signalling pathway in human peripheral blood mononuclear cells (PBMCs), while elevated NOD1 expression in tumour tissues was consistently associated with poor prognosis in patients with CRC‐LM. The gene discussed is NOD1; the disease is neoplasm.